Appraisals - ASAR & FAR

15/07/2020

Final Recommendation: dasatinib (Sprycel) 103

14/07/2020

Final Recommendation: buprenorphine/naloxone (Suboxone) 70

31/07/2019

Final Recommendation: aprepitant (EMEND) 2937

31/07/2019

Final Recommendation: ceftolozane/tazobactam (Zerbaxa) 2356

31/07/2019

Final Recommendation: elvitegravir combination (Genvoya) 2248

31/07/2019

Final Recommendation: evolocumab (Repatha) 2866

31/07/2019

Final Recommendation: olanzapine (ZypAdhera) 2991

31/07/2019

Final Recommendation: netupitant/palonosetron (Akynzeo) 1484

27/08/2019

Final Recommendation: ranolazine (Ranexa) 723

24/02/2020

Final Recommendation: emtricitabine-tenofovir (Truvada) 1625

06/08/2019

Review of existing advice: insulin detemir (Levemir) 1427

10/02/2020

Final Recommendation: darunavir (Prezista) 101

10/02/2020

Final Recommendation: cetuximab (Erbitux) 81

01/08/2019

Final Recommendation: velaglucerase alfa (VPRIV) 571

22/08/2019

Final Recommendation: valganciclovir (Valcyte) 824

22/08/2019

Final Recommendation: valganciclovir (Valcyte) 812

01/08/2019

Final Recommendation: ustekinumab (Stelara) 2068

31/07/2019

Final Recommendation: ursodeoxycholic acid (Ursofalk) 2610

31/07/2019

Final Recommendation: umeclidinium vilanterol (AnoroEllipta) 1038

01/08/2019

Final Recommendation: umeclidinium (Incruse) 1352